ROBERT L. VAN NOSTRAND - 09 Jun 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
09 Jun 2022
Transactions value $
$0
Form type
4
Filing time
13 Jun 2022, 17:01:05 UTC
Previous filing
26 May 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Award $0 +16,757 $0.000000 16,757 09 Jun 2022 Common Stock 16,757 $55.48 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.